我国在研新药数量占全球数量比例超过20%，跃居全球新药研发的第二位。在A股市场上，今年上半年150家创新药公司豪掷342亿元“竞速”研发，同比增长约3.86%。业绩表现同样不俗，超七成创新药企实现盈利，不少公司出海业务表现亮眼。来源：摄图网我国跃居全球新药研发第二位9月11日，国新办举行新闻发布会，介绍“十四五”时期卫生健康工作发展成就。国家卫生健康委副主任郭燕红介绍，“十四五”期间，广大卫生健康...
Source Link我国在研新药数量占全球数量比例超过20%，跃居全球新药研发的第二位。在A股市场上，今年上半年150家创新药公司豪掷342亿元“竞速”研发，同比增长约3.86%。业绩表现同样不俗，超七成创新药企实现盈利，不少公司出海业务表现亮眼。来源：摄图网我国跃居全球新药研发第二位9月11日，国新办举行新闻发布会，介绍“十四五”时期卫生健康工作发展成就。国家卫生健康委副主任郭燕红介绍，“十四五”期间，广大卫生健康...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.